EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cytokine Storm in COVID-19: Exploring IL-6 Signaling and Cytokine-Microbiome Interactions as Emerging Therapeutic Approaches

Tudorita Gabriela Paranga iD, Ivona Mitu iD, Mariana Pavel-Tanasa iD, Manuel Florin Rosu, Ionela-Larisa Miftode iD, Daniela Constantinescu iD, Maria Obreja iD, Claudia Elena Plesca iD, Egidia Miftode

International Journal of Molecular Sciences · 24.10.2024 · 25 (21) · 11411

DOI: 10.3390/ijms252111411 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.10.2024. Verfasst von Tudorita Gabriela Paranga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases (Internal Medicine II), Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Roma…. Hauptthemen laut MEDLINE: COVID-19, Cytokine Release Syndrome, Interleukin-6, Signal Transduction. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grigore T. Popa University of Medicine and Pharmacy of Iasi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IL-6 remains a key molecule of the cytokine storms characterizing COVID-19, exerting both proinflammatory and anti-inflammatory effects. Emerging research underscores the significance of IL-6 trans-signaling over classical signaling pathways, which has shifted the focus of therapeutic strategies. Additionally, the synergistic action of TNF-α and IFN-γ has been found to induce inflammatory cell death through PANoptosis, further amplifying the severity of cytokine storms. Long COVID-19 patients, as well as those with cytokine storms triggered by other conditions, exhibit distinct laboratory profiles, indicating the need for targeted approaches to diagnosis and management. Growing evidence also highlights the gut microbiota’s crucial role in modulating the immune response during COVID-19 by affecting cytokine production, adding further complexity to the disease’s immunological landscape. Targeted intervention strategies should focus on specific cytokine cutoffs, though accurate cytokine quantification remains a clinical challenge. Current treatment strategies are increasingly focused on inhibiting IL-6 trans-signaling, which offers promise for more precise therapeutic approaches to manage hyperinflammatory responses in COVID-19. In light of recent discoveries, this review summarizes key research findings on cytokine storms, particularly their role in COVID-19 and other inflammatory conditions. It explores emerging therapeutic strategies targeting cytokines like IL-6, TNF-α, and IFN-γ, while also addressing open questions, such as the need for better biomarkers to detect and manage cytokine storms. Additionally, the review highlights ongoing challenges in developing targeted treatments that mitigate hyperinflammation without compromising immune function, emphasizing the importance of continued research in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cytokine Release SyndromeInterleukin-6Signal TransductionSARS-CoV-2Gastrointestinal MicrobiomeHumansCytokinesCOVID-19 Drug Treatment

Stichwörter der Autor:innen

COVID-19IFN-γIL-6TNF-αcytokine stormtocilizumab

Substanzen

Interleukin-6Cytokines

Autor:innen und Institutionen

  • Department of Infectious Diseases (Internal Medicine II), Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • St. Parascheva Clinical Hospital for Infectious Diseases, 700116 Iasi, Romania.
  • Department of Morpho-Functional Sciences II, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Department of Immunology, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Laboratory of Immunology, St. Spiridon County Clinical Emergency Hospital, 700101 Iasi, Romania.
  • Department of Preventive Medicine and Interdisciplinarity, Faculty of Medicine, University of Medicine and Pharmacy Grigore. T. Popa, 700115 Iasi, Romania.

ORCID-Profile: Tudorita Gabriela Paranga, Ivona Mitu, Mariana Pavel-Tanasa, Ionela-Larisa Miftode, Daniela Constantinescu, Maria Obreja, Claudia Elena Plesca

Förderung

  • Grigore T. Popa University of Medicine and Pharmacy of Iasi

Zitieren

APA

Paranga, T. G., Mitu, I., Pavel-Tanasa, M., Rosu, M. F., Miftode, I. L., Constantinescu, D., Obreja, M., Plesca, C. E., & Miftode, E. (2024). Cytokine Storm in COVID-19: Exploring IL-6 Signaling and Cytokine-Microbiome Interactions as Emerging Therapeutic Approaches. International Journal of Molecular Sciences, 25(21), 11411. https://doi.org/10.3390/ijms252111411

Vancouver

Paranga TG, Mitu I, Pavel-Tanasa M, Rosu MF, Miftode IL, Constantinescu D, et al. Cytokine Storm in COVID-19: Exploring IL-6 Signaling and Cytokine-Microbiome Interactions as Emerging Therapeutic Approaches. International Journal of Molecular Sciences. 2024;25(21):11411. doi:10.3390/ijms252111411

BibTeX
@article{Paranga2024,
  author = {Paranga, Tudorita Gabriela and Mitu, Ivona and Pavel-Tanasa, Mariana and Rosu, Manuel Florin and Miftode, Ionela-Larisa and Constantinescu, Daniela and Obreja, Maria and Plesca, Claudia Elena and Miftode, Egidia},
  title = {Cytokine Storm in COVID-19: Exploring IL-6 Signaling and Cytokine-Microbiome Interactions as Emerging Therapeutic Approaches},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {21},
  pages = {11411},
  doi = {10.3390/ijms252111411}
}
Kostenlos starten →